BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21895584)

  • 1. PatientsLikeMe and the tale of three brothers.
    Trevena LJ
    Med J Aust; 2011 Sep; 195(5):258-9. PubMed ID: 21895584
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurologic degenerative disorders.
    Ross AP
    Nurs Clin North Am; 1999 Sep; 34(3):725-42. PubMed ID: 10433655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke and neurodegenerative disorders. 4. Neurodegenerative disorders.
    Bryant PR; Geis CC; Moroz A; O'neill BJ; Bogey RA
    Arch Phys Med Rehabil; 2004 Mar; 85(3 Suppl 1):S21-33. PubMed ID: 15034853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changing neurology--from diagnostic to therapeutic discipline].
    Smits A; Andsberg G; Andersen PM; Andersson M; Fredrikson S; Gunnarsson M; Kumlien E; Lycke J; Jensen SM; Remahl IN; Nyholm D
    Lakartidningen; 2008 Sep 3-9; 105(36):2413-6. PubMed ID: 18831452
    [No Abstract]   [Full Text] [Related]  

  • 5. Stem cells for the treatment of neurodegenerative diseases.
    Dantuma E; Merchant S; Sugaya K
    Stem Cell Res Ther; 2010 Dec; 1(5):37. PubMed ID: 21144012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroscience. Versatile cells against intractable diseases.
    Holden C
    Science; 2002 Jul; 297(5581):500-2. PubMed ID: 12142509
    [No Abstract]   [Full Text] [Related]  

  • 7. [ACTH therapy of certain nervous diseases].
    FOG T
    Ugeskr Laeger; 1952 Nov; 114(47):1677-85. PubMed ID: 13029280
    [No Abstract]   [Full Text] [Related]  

  • 8. Stem cells for Parkinson disease and ALS: replacement or protection?
    Svendsen CN; Langston JW
    Nat Med; 2004 Mar; 10(3):224-5. PubMed ID: 14991036
    [No Abstract]   [Full Text] [Related]  

  • 9. [Plasmapheresis in the treatment of nervous system diseases].
    Zaleska B
    Neurol Neurochir Pol; 1984; 18(5):409-13. PubMed ID: 6527723
    [No Abstract]   [Full Text] [Related]  

  • 10. Stem cell therapy in treatment of different diseases.
    Larijani B; Esfahani EN; Amini P; Nikbin B; Alimoghaddam K; Amiri S; Malekzadeh R; Yazdi NM; Ghodsi M; Dowlati Y; Sahraian MA; Ghavamzadeh A
    Acta Med Iran; 2012; 50(2):79-96. PubMed ID: 22359076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsibilities of Health Care Professionals in Counseling and Educating Patients With Incurable Neurological Diseases Regarding "Stem Cell Tourism": Caveat Emptor.
    Bowman M; Racke M; Kissel J; Imitola J
    JAMA Neurol; 2015 Nov; 72(11):1342-5. PubMed ID: 26322563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALSUntangled No. 11: Nu Tech Mediworld.
    ALSUntangled Group
    Amyotroph Lateral Scler; 2011 Jul; 12(4):309-11. PubMed ID: 21702736
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroprotective activities of regulatory T cells.
    Gendelman HE; Appel SH
    Trends Mol Med; 2011 Dec; 17(12):687-8. PubMed ID: 21996344
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatments in Neurology: The Winding Road from 1897 to 2022.
    Tatu L; Bogousslavsky J
    Eur Neurol; 2022; 85(5):367-370. PubMed ID: 35850103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Information-seeking Behavior and Information Needs in Patients With Amyotrophic Lateral Sclerosis: Analyzing an Online Patient Community.
    Oh J; Kim JA
    Comput Inform Nurs; 2017 Jul; 35(7):345-351. PubMed ID: 28225381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tolbutamide in the treatment of Parkinson's disease and multiple sclerosis].
    CASTEX MR
    Prensa Med Argent; 1961 Jul; 48():2005-9. PubMed ID: 13877221
    [No Abstract]   [Full Text] [Related]  

  • 17. [Limitations of neurologic intensive care].
    Schuchardt V; Biniek R; Heitmann R
    Anasth Intensivther Notfallmed; 1984 Apr; 19(2):65-70. PubMed ID: 6731761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroendocrine aspects of the pathogenesis and treatment of disseminated sclerosis and lateral amyotrophic sclerosis].
    Golovkin VI; Korovin KF; Iampol'skaia LI; Dobrov SA
    Sov Med; 1990; (5):31-3. PubMed ID: 2117778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical observations on the use of pyridostigmine (mestinon) in cases of amyotrophic lateral sclerosis & multiple sclerosis].
    COLOMBO P
    Gazz Med Ital; 1957 Dec; 116(12):583-5. PubMed ID: 13524593
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasmapheresis in neurologic disorders.
    Dau PC
    Muscle Nerve; 1980; 3(6):529. PubMed ID: 6161306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.